Medtronic vs. Teleflex: Catheter Patent Dismissed in Medical Device Case
What would you like to do next?
Choose your path based on your current needs:
📋 Case Summary
| Case Name | Medtronic, Inc. v. Teleflex Life Sciences Ltd. |
| Court | U.S. District Court for the District of Minnesota |
| Duration | 344 days Under 1 year |
| Outcome | Defendant Win — Case Dismissed |
| Patents at Issue | |
| Accused Products | Teleflex’s Catheter Products |
Case Overview
The Parties
⚖️ Plaintiff
A global medical technology leader headquartered in Dublin, Ireland, with significant U.S. operations in Minneapolis, Minnesota. The company holds one of the largest cardiovascular device patent portfolios in the world.
🛡️ Defendant
A diversified medical device manufacturer with a strong presence in vascular access, respiratory, and cardiac care products, including widely used guide extension catheters.
The Patent(s) at Issue
This litigation centered on **U.S. Patent No. 7,736,355** — a patent covering catheter-related technology with claims directed at structural and functional innovations in intravascular catheter systems. The patent’s claims address configurations relevant to guide catheter extensions used in coronary interventions.
- • US 7,736,355 — Catheter-related technology covering structural & functional innovations.
Developing a similar medical device?
Check if your catheter design might infringe this or related patents before launch.
The Verdict & Legal Analysis
Outcome
The case was dismissed, with no disclosed damages award and no reported injunctive relief. The dismissal designation as the basis of termination indicates the matter did not proceed to a jury or bench verdict on the merits of infringement or invalidity.
Verdict Cause Analysis
The verdict cause recorded for this matter is “Without Merit/Frivolous,” a categorization that carries significant analytical weight. This designation suggests that the presiding court or the parties’ own litigation assessment led to a determination that the claims as asserted lacked sufficient legal or factual foundation to proceed.
In patent litigation, a “without merit” dismissal can arise from several procedural and substantive pathways, including claim construction adverse outcomes, successful invalidity challenges, or voluntary dismissal following strategic reassessment after discovery.
Freedom to Operate (FTO) Analysis
This case highlights critical IP risks in medical device development, particularly for catheter technology. Choose your next step:
📋 Understand This Case’s Impact
Learn about the specific risks and implications from this litigation for medical devices.
- View all related patents in this technology space
- See which companies are most active in catheter patents
- Understand claim construction patterns for medical devices
🔍 Check My Product’s Risk
Run a comprehensive FTO analysis for your own medical device technology or product.
- Input your product description or technical features
- AI identifies potentially blocking patents
- Get actionable risk assessment report
High Risk Area
Intravascular catheter systems
Related Patents
In catheter technology space
Design-Around Options
Available for many claims
✅ Key Takeaways
Dismissals categorized as “without merit” can trigger § 285 exceptional case analysis — evaluate fee-shifting exposure at filing.
Search related case law →Claim construction risk in catheter technology remains high; invest in Markman preparation before district court proceedings.
Explore precedents →Frequently Asked Questions
The case involved U.S. Patent No. 7,736,355, covering catheter technology relevant to intravascular catheter systems used in cardiovascular interventions.
The case was dismissed with a verdict cause categorized as “Without Merit/Frivolous,” indicating the asserted claims did not survive legal scrutiny. Specific judicial reasoning was not publicly detailed in available case records.
It signals ongoing claim construction risk for catheter patent holders and reinforces the value of pre-litigation FTO and claim mapping analysis for both innovators and manufacturers in the medical device space.
Companies can protect themselves by conducting rigorous freedom-to-operate (FTO) analysis before finalizing medical device designs, documenting design evolution thoroughly, considering design-around strategies for high-risk device elements, and filing their own design patents early in the product development cycle. PatSnap Eureka’s FTO tools help R&D and IP teams identify potentially blocking medical device patents before products go to market.
Ready to Strengthen Your Patent Strategy?
Join 18,000+ IP professionals using PatSnap Eureka to conduct prior art searches, draft patents, and analyse competitive landscapes with AI-powered precision.
References
- Research related cases on PACER
- U.S. Patent No. 7,736,355 on Google Patents
- U.S. District Court for the District of Minnesota — Official Docket Portal
- PatSnap — IP Intelligence Solutions for Law Firms
This article is for informational purposes only and does not constitute legal advice. All case information is drawn from publicly available court records. For platform capabilities, visit PatSnap.